Profil
Pontus Ottosson is currently the CEO & Head of Investments at Chalmers Ventures AB since 2024.
He is also the Director at Oxeon AB, Minalyze AB, Prigo AB, Tummy Lab AB, Elypta AB, and An Prima AB. Mr. Ottosson has previously worked as the CEO at Puls AB, Chairman at LIDDS AB, Managing Director at Aqilion AB, Director at AcuCort AB, Independent Director at Monivent AB, and Director at Stayble Therapeutics AB. He graduated from Chalmers University of Technology in 2002.
Postes actifs de Pontus Ottosson
| Sociétés | Poste | Début |
|---|---|---|
Chalmers Ventures AB
Chalmers Ventures AB Investment ManagersFinance Chalmers Ventures invests in companies located in Sweden. The firm targets companies operating in the field of technology sector. It provides financing for pre-seed, seed & growth stage capital requirements with an investment size of up to SEK 1 million in pre-seed stage, up to SEK 5 million in seed stage and up to SEK 20 million in growth stage transactions. It also act as co-investor. | Directeur Général | 01/01/2024 |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Directeur/Membre du Conseil | 01/01/2017 |
An Prima AB | Directeur/Membre du Conseil | 01/01/2002 |
Oxeon AB
Oxeon AB TextilesProcess Industries Provides tape weaving technologies and tape woven materials | Directeur/Membre du Conseil | 01/01/2019 |
Minalyze AB
Minalyze AB Electronic Equipment/InstrumentsElectronic Technology Develops scanning instruments | Directeur/Membre du Conseil | 01/01/2019 |
Prigo AB | Directeur/Membre du Conseil | 01/01/2012 |
Tummy Lab AB
Tummy Lab AB Miscellaneous Commercial ServicesCommercial Services Operates an online portal for relief and management of chronic gastrointestinal diseases and disorders | Directeur/Membre du Conseil | 01/01/2018 |
Anciens postes connus de Pontus Ottosson
| Sociétés | Poste | Fin |
|---|---|---|
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is an active manager which invests companies located in Sweden. The firm follows of life science companies. It provides financing for early-stage capital requirements. | Directeur Général | 25/01/2017 |
| LIDDS AB | Président | - |
| ░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Pontus Ottosson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is an active manager which invests companies located in Sweden. The firm follows of life science companies. It provides financing for early-stage capital requirements. | Finance |
Oxeon AB
Oxeon AB TextilesProcess Industries Provides tape weaving technologies and tape woven materials | Process Industries |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Minalyze AB
Minalyze AB Electronic Equipment/InstrumentsElectronic Technology Develops scanning instruments | Electronic Technology |
AcuCort AB
AcuCort AB Pharmaceuticals: MajorHealth Technology Develops glucocorticoids for the patients suffering from acute allergic conditions | Health Technology |
Monivent AB
Monivent AB Medical SpecialtiesHealth Technology Develops device to monitor manual ventilation given to newborns unable to breathe | Health Technology |
Prigo AB | |
Chalmers Ventures AB
Chalmers Ventures AB Investment ManagersFinance Chalmers Ventures invests in companies located in Sweden. The firm targets companies operating in the field of technology sector. It provides financing for pre-seed, seed & growth stage capital requirements with an investment size of up to SEK 1 million in pre-seed stage, up to SEK 5 million in seed stage and up to SEK 20 million in growth stage transactions. It also act as co-investor. | Finance |
Stayble Therapeutics AB
Stayble Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops drugs to treat disco genic chronic low back pain | Health Technology |
Tummy Lab AB
Tummy Lab AB Miscellaneous Commercial ServicesCommercial Services Operates an online portal for relief and management of chronic gastrointestinal diseases and disorders | Commercial Services |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Technology Services |
An Prima AB | |
Puls AB
Puls AB Environmental ServicesIndustrial Services Provides sewage, industrial and environmental services | Industrial Services |
















